Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott B Patten

Showing results (281-290 of 534) with videos related to

Pageof 54
Sort By:
Neurology|November 30, 2022
Direct Health Care Costs Associated With Multiple Sclerosis: A Population-Based Cohort Study in British Columbia, Canada, 2001-2020Amir Khakban, Elisabet Rodriguez Llorian, Kristina D Michaux, et al.
CNS Neuroscience & Therapeutics|July 23, 2013
Quetiapine fumarate for the treatment of multiple sclerosis: focus on myelin repairSimon Zhornitsky, Voon Wee Yong, Marcus W Koch, et al.
Journal of Affective Disorders|February 25, 2020
The accuracy of depression risk perception in high risk CanadiansJianLi Wang, Rachel Smail-Crevier, Molly Nannarone, et al.
The International Journal of Eating Disorders|September 26, 2024
Postdischarge Mortality in a Cohort Hospitalized With Anorexia NervosaScott B Patten, Gina Dimitropoulos, Julia Hews-Girard, et al.
Plos One|May 4, 2026
Community perceptions of natural supports and their approaches: A Canadian grounded theory study with Connections FirstJessica-Lynn A Walsh, Kiran Pohar Manhas, Nikki Stephenson, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 18, 2015
Descriptive epidemiology of major depressive disorder in Canada in 2012Scott B Patten, Jeanne V A Williams, Dina H Lavorato, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 8, 2015
Antidepressant use in Canada has stopped increasingScott B Patten, Jeanne V A Williams, Dina H Lavorato, et al.
Neurology|November 1, 2015
Differences in the burden of psychiatric comorbidity in MS vs the general populationRuth Ann Marrie, John D Fisk, Helen Tremlett, et al.
Epilepsia|June 10, 2017
The prevalence of anxiety and associated factors in persons with epilepsyTram Pham, Khara M Sauro, Scott B Patten, et al.
Journal of Psychiatric Research|January 27, 2012
Persistent heavy smoking as risk factor for major depression (MD) incidence--evidence from a longitudinal Canadian cohort of the National Population Health SurveySalma M Khaled, Andrew G Bulloch, Jeanne V A Williams, et al.
Pageof 54

Showing results (281-290 of 534) with videos related to

Sort By:
Pageof 54
Neurology|November 30, 2022
Direct Health Care Costs Associated With Multiple Sclerosis: A Population-Based Cohort Study in British Columbia, Canada, 2001-2020Amir Khakban, Elisabet Rodriguez Llorian, Kristina D Michaux, et al.
CNS Neuroscience & Therapeutics|July 23, 2013
Quetiapine fumarate for the treatment of multiple sclerosis: focus on myelin repairSimon Zhornitsky, Voon Wee Yong, Marcus W Koch, et al.
Journal of Affective Disorders|February 25, 2020
The accuracy of depression risk perception in high risk CanadiansJianLi Wang, Rachel Smail-Crevier, Molly Nannarone, et al.
The International Journal of Eating Disorders|September 26, 2024
Postdischarge Mortality in a Cohort Hospitalized With Anorexia NervosaScott B Patten, Gina Dimitropoulos, Julia Hews-Girard, et al.
Plos One|May 4, 2026
Community perceptions of natural supports and their approaches: A Canadian grounded theory study with Connections FirstJessica-Lynn A Walsh, Kiran Pohar Manhas, Nikki Stephenson, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 18, 2015
Descriptive epidemiology of major depressive disorder in Canada in 2012Scott B Patten, Jeanne V A Williams, Dina H Lavorato, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 8, 2015
Antidepressant use in Canada has stopped increasingScott B Patten, Jeanne V A Williams, Dina H Lavorato, et al.
Neurology|November 1, 2015
Differences in the burden of psychiatric comorbidity in MS vs the general populationRuth Ann Marrie, John D Fisk, Helen Tremlett, et al.
Epilepsia|June 10, 2017
The prevalence of anxiety and associated factors in persons with epilepsyTram Pham, Khara M Sauro, Scott B Patten, et al.
Journal of Psychiatric Research|January 27, 2012
Persistent heavy smoking as risk factor for major depression (MD) incidence--evidence from a longitudinal Canadian cohort of the National Population Health SurveySalma M Khaled, Andrew G Bulloch, Jeanne V A Williams, et al.
Pageof 54